| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.84B | 2.61B | 2.70B | 2.17B | 2.22B | 884.50M |
| Gross Profit | 778.70M | 728.40M | 848.40M | 121.30M | 510.40M | 232.10M |
| EBITDA | 339.80M | 314.60M | 393.90M | -376.00M | 85.00M | 160.10M |
| Net Income | 198.30M | 199.90M | 354.80M | -386.80M | 58.10M | 143.80M |
Balance Sheet | ||||||
| Total Assets | 12.46B | 12.52B | 12.87B | 11.04B | 10.62B | 3.54B |
| Cash, Cash Equivalents and Short-Term Investments | 3.12B | 3.57B | 6.10B | 4.33B | 2.08B | 526.00M |
| Total Debt | 682.50M | 639.10M | 786.20M | 778.00M | 816.70M | 114.30M |
| Total Liabilities | 10.25B | 10.59B | 10.34B | 8.95B | 8.12B | 1.97B |
| Stockholders Equity | 2.21B | 1.94B | 2.51B | 2.07B | 2.50B | 1.56B |
Cash Flow | ||||||
| Free Cash Flow | 232.10M | 74.70M | 581.30M | 292.50M | 1.60M | 73.36M |
| Operating Cash Flow | 232.10M | 74.70M | 581.30M | 293.30M | 1.60M | 73.36M |
| Investing Cash Flow | 437.70M | 343.60M | -332.20M | -1.30B | 208.60M | 6.11M |
| Financing Cash Flow | -743.70M | -625.00M | -61.50M | -23.70M | 24.30M | -19.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $2.68B | 6.31 | 17.62% | ― | 22.79% | -5.17% | |
77 Outperform | $12.70B | 7.65 | 14.98% | 0.57% | -3.96% | -48.08% | |
76 Outperform | $2.35B | 13.02 | 8.09% | ― | 7.87% | -4.68% | |
74 Outperform | $12.93B | 15.20 | 7.19% | 1.76% | 2.10% | 19.23% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $465.45M | -292.60 | -0.28% | ― | 5.83% | -101.38% | |
44 Neutral | $8.06M | -2.75 | -50.32% | ― | ― | 55.30% |
On October 31, 2025, SiriusPoint Ltd. completed the sale of its wholly owned supplemental health insurance program manager, ArmadaCare, to Ambac Financial Group Inc. for $250 million. This transaction, initially announced on September 29, 2025, marks a strategic move for SiriusPoint, potentially impacting its market positioning and operational focus.
The most recent analyst rating on (SPNT) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.
On October 30, 2025, SiriusPoint Ltd. announced its third quarter results for 2025, highlighting a strong performance with a core combined ratio of 89.1% and an 11% increase in underwriting income. The company reported a return on equity of 17.7% and a significant growth in gross premiums written, marking the sixth consecutive quarter of double-digit growth. The announcement also included a quarterly cash dividend approval and the expected value increase from the sale of two MGA investments. Despite challenges from California wildfires and the aviation sector, SiriusPoint’s strategic growth and operational improvements have positioned it well within its target range, with a positive outlook upgrade from S&P.
The most recent analyst rating on (SPNT) stock is a Hold with a $19.50 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.
On October 13, 2025, SiriusPoint Ltd. announced the resignation of Evan Cabat, the Chief Accounting Officer, effective October 31, 2025, as he pursues another opportunity. The company clarified that his departure is not due to any disagreements regarding financial or operational matters. Jim McKinney, the Chief Financial Officer, will take over Cabat’s responsibilities, ensuring continuity in the company’s financial leadership.
The most recent analyst rating on (SPNT) stock is a Hold with a $20.00 price target. To see the full list of analyst forecasts on SiriusPoint stock, see the SPNT Stock Forecast page.